Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Conforti, P
It is a synthetic 15-amino-acid peptide derived from a sequence first identified in human gastric juice in the 1990s
Phase 2 cagrilintide alone ~10.8% body weight reduction at 26 weeks (4.5mg) Phase 2 CagriSema combo ~15.6% body weight reduction at 32 weeks Phase 3 REDEFINE 1 ~22.7% body weight reduction at 68 weeks Phase 2 CagriSema combination trial The Phase 2 trial of CagriSema was published in The Lancet in 2023, and its results attracted immediate attention
Parasitol Res 114(10):37753781 Gmez-Zorita S, Milton-Laskibar I, Eseberri I, Beaumont P, Courtois A, Krisa S, Portillo MP(2023) Beneficial effects of -viniferin on obesity and related health alterations
Bull Exp Biol Med 2012;153:2558
a 1 mg dose = 0.40 mL = 40 units)
US$ 27.10
US$ 27.47
US$ 25.83
US$ 20.75
US$ 25.40
US$ 22.37
